Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib – novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled
Agrawal N et al. Cell Commun Signal, May 2026 (epub ahead of print) – open access publication
Link to full abstract